Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial (original) (raw)

Summary

The absolute bioavailability of fenspiride has been studied in twelve healthy volunteers. It was administered IV and orally in single doses of 80 mg fenspiride hydrochloride according to a randomised crossover pattern.

Following IV administration, the plasma clearance of fenspiride was about 184 ml·min−1, and its apparent volume of distribution was moderately large (2151).

When given orally as a tablet, fenspiride exhibited fairly slow ab- sorption; the maximum plasma concentration (206 ng·ml−1) was achieved 6 h after administration. The absolute bioavailability was almost complete (90%). The tablet had slow release characteristics. The elimination half-life obtained from the plasma data was 14 to 16 h independent of the route of administration.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carre P, Pipy B, Pinelli E, Forgue MF, Beraud M, Didier A, Leophonte P (1991) In vitro effects of fenspiride on the production of free oxygen radicals, prostaglandins and leukotrienes by guinea-pig alveolar macrophages. Eur Respir Rev 1: 79–85
    Google Scholar
  2. Chapelain B, Neliat G, Bodinier MC, Jean T, Evrard Y, Gargouil YM (1991) Role of the epithelium in the action of fenspiride on the isolated guinea-pig and rat trachea. Eur Respir Rev 1: 86–92
    Google Scholar
  3. Evrard Y, Kato G, Bodinier MC, Chapelain B (1991) Fenspiride and inflammation in experimental pharmacology. Eur Respir Rev 1: 93–100
    Google Scholar
  4. Giacchero G, Taranger J (1982) Pneumorel retard au long cours dans le traitement des bronchites chroniques. Vie Méd 63: 791–794
    Google Scholar
  5. Kafe H (1984) Intérêt du Pneumorel 80 mg dans le traitement de l'insuffisance respiratoire chronique. Vie Méd 65: 200–203
    Google Scholar
  6. Turrisi E, Mea A, Bruno G, Vitagliano A (1984) Studio controllato del fenspiride ritardo in ambito pneumologico. Clin Ther 111: 339–346
    Google Scholar
  7. Olivieri D, Del Donno M (1987) Etude de l'action du fenspiride sur la clairance mucociliaire chez le bronchitique chronique. JIM 96: 395–398
    Google Scholar
  8. Leophonte P, Thack KS, Voigt JJ, Rouquet RM, Didier A (1986) Le fenspiride (Pneumorel 80 mg) dans le traitement des bronchopneumopathies chroniques obstructives. Vie Méd 23–24: 1047–1051
    Google Scholar
  9. Akoun G, Arnaud F, Blanchon F, Botto JM, Cerf C, Clavier J, Derenne JP, Leophonte P, Nouvet G, Paramelle B, Patron P, Prefaut C, Verlardocchio JM (1991) Effects of fenspiride on airway function and blood gases in stable COPD patients. Eur Respir Rev 1: 111–125
    Google Scholar
  10. Evrard Y, Lhoste F, Advenier C, Duhault J (1986) Le fenspiride et le système broncho-pulmonaire: nouvelle approche pharmacologique. Semaine Hôp 62: 1375–1381
    Google Scholar
  11. Megel H, Holmes P, Zalipsky J, Schemano I, Beiler JM (1973) Fenspiride 14C: its distribution, excretion and metabolism in the rat. Arch Int Pharmacodyn Ther 201: 90–99
    Google Scholar
  12. Jeanniot JP, Chezaubernard C (1991) Pharmacokinetic properties of fenspiride: an update. Eur Resp Rev 1: 101–104
    Google Scholar
  13. Sauveur C, Baune A, Vergnes N, Jeanniot JP (1989) Quantitative determination of fenspiride in human plasma and urine by liquid chromatography with electrochemical or ultraviolet detection J Pharm Biomed Anal 7: 1799–1804
    Google Scholar
  14. Weiner DL (1986) NONLIN 84/PC NONLIN: software for the statistical analysis of nonlinear models. Methods Find Exp Clin Pharmacol 8: 625–628
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. Servicio de Farmacologia Clinica, Unidad de Fase I, Centro de Investigacion en Farmacologia Aplicada, Universidad de Navarra, Rampelona, Spain
    B. Montes, M. Catalan & J. M. Honorato
  2. Laboratorios Servier, Madrid, Spain
    A. Roces
  3. Bio-Pharmacie Servier, Orléans, France
    J. P. Jeanniot

Authors

  1. B. Montes
    You can also search for this author inPubMed Google Scholar
  2. M. Catalan
    You can also search for this author inPubMed Google Scholar
  3. A. Roces
    You can also search for this author inPubMed Google Scholar
  4. J. P. Jeanniot
    You can also search for this author inPubMed Google Scholar
  5. J. M. Honorato
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Montes, B., Catalan, M., Roces, A. et al. Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial.Eur J Clin Pharmacol 45, 169–172 (1993). https://doi.org/10.1007/BF00315501

Download citation

Key words